Mizuho Markets Americas LLC Sells 1,945,500 Shares of GE HealthCare Technologies Inc. $GEHC

Mizuho Markets Americas LLC lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 99.3% in the first quarter, HoldingsChannel.com reports. The firm owned 12,800 shares of the company’s stock after selling 1,945,500 shares during the quarter. Mizuho Markets Americas LLC’s holdings in GE HealthCare Technologies were worth $911,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Empowered Funds LLC lifted its position in shares of GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares during the period. Acadian Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $259,000. Cresset Asset Management LLC increased its position in shares of GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after buying an additional 865 shares during the period. Jump Financial LLC raised its stake in GE HealthCare Technologies by 317.6% during the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after buying an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL raised its stake in GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after buying an additional 320 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other news, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kevin Lobo acquired 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $64.18 per share, with a total value of $641,800.00. Following the purchase, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 21,847 shares of company stock worth $1,361,355 over the last three months. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Up 0.9%

Shares of NASDAQ GEHC opened at $61.99 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market cap of $28.20 billion, a PE ratio of 14.83, a P/E/G ratio of 1.67 and a beta of 0.72. The company’s fifty day simple moving average is $63.64 and its 200 day simple moving average is $71.31. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period last year, the firm posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Analyst Ratings Changes

A number of analysts have commented on GEHC shares. BNP Paribas Exane cut their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Evercore set a $80.00 price objective on GE HealthCare Technologies in a research report on Thursday, April 30th. Royal Bank Of Canada initiated coverage on GE HealthCare Technologies in a research note on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 price objective on the stock. Mizuho cut their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Finally, Oppenheimer restated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $76.41.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.